Cannabis Stock News - Nextleaf (CSE: OILS) Provides Updates on Glacial Gold(TM) Products for the Ontario and British Columbia Markets
Glacial Gold™ High THC Holiday Fruitquake vape to launch exclusively in Ontario
Nextleaf expands Glacial Gold™ portfolio with its first CBN product
Vancouver, British Columbia - September 15, 2022 (Newsfile Corp.) (Investorideas.com Newswire) Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf" or the "Company"), a federally regulated manufacturer and distributor of cannabis extracts including vapes and oils, is pleased to announce the launch of a new high THC vape in Ontario and additional product updates in British Columbia, including the Company's first cannabinol ("CBN") product.
Ontario Glacial Gold™ Update
Nextleaf is excited to announce the launch of a new limited drop Glacial Gold™ vape for Ontario. The new Glacial Gold™ High THC Holiday Fruitquake is a one-gram THC vape cartridge with a holiday inspired flavour that is sweet, fruity, and cakey, reminiscent of your favourite holiday fruitcake.
The Company has received its largest purchase order from the province to date and the new Glacial Gold™ offering is expected to be available at retail stores across Ontario and at osc.ca in October 2022.
British Columbia Glacial Gold™ Update
Nextleaf has completed its initial shipment of its new one-gram Glacial Gold™ CBD 3:1 Vape in the Company's signature Berry Lemonade flavour. Consumers can now find this new product in retail stores throughout B.C.
Additionally, Nextleaf is delighted to announce its expansion into the rare cannabinoids market segment, specifically CBN, with the launch of Glacial Gold™ After Hours CBN:THC Drops. Formulated for night-time use, Glacial Gold™ After Hours CBN:THC Drops is the perfect blend of THC and CBN to help consumers unwind after a long day.
Along with Glacial Gold™ After Hours CBN:THC Drops, there are several new Glacial Gold™ SKU listings ("SKUs") that are set to launch between now and the end of fall in British Columbia. The additional SKUs approved are Glacial Gold™ Session THC Lime Ginger Haze, Glacial Gold™ THC 10mg Softgels, and Glacial Gold™ Rise & Shine CBD Drops.
Glacial Gold™ Session THC Lime Ginger Haze is a full potency one-gram THC vape cartridge. The lime ginger haze vape is cocktail inspired and consists of a citrus, lime-forward flavour, with a subtle hint of ginger. The Company has received its initial purchase order from the province and expects the product to be available in B.C. in early October.
Glacial Gold™ THC 10mg Softgels will launch in B.C. in ten and fifty-pack formats powered by Nextleaf's high-purity cannabis distillate in a base of organic coconut MCT oil expertly encapsulated for a premium consumption experience, without premium pricing. Glacial Gold™ Softgels will provide unparalleled value in quality and price per milligram compared to other regulated capsules and edible products.
Glacial Gold™ Rise & Shine CBD Drops is Nextleaf's first product utilizing its technology to produce its excise-exempt ingredient, THC-free Broad Spectrum CBD distillate. The new product is a more holistic alternative to CBD isolates, perfect to start the day with no concern of THC consumption.
About Nextleaf Solutions Ltd.
Nextleaf® is a federally regulated manufacturer and distributor of cannabis vapes and oils under its award-winning prohibition-era brand, Glacial Gold™. The Company's multi-patented ingredient processing technology transforms cannabis and hemp biomass into high-purity distillate at an industrial scale. Nextleaf is a low-cost producer of cannabis oils, and supplier of THC and CBD ingredients to qualified wholesale partners across Canada. Nextleaf is the first publicly traded company to be issued a U.S. patent for the industrial extraction and purification of cannabinoids. The Company has been issued 18 U.S. patents, and over 95 patents globally, on cannabinoid processing including distillation and acetylation. Nextleaf develops cannabinoid-based formulations and delivery technology through its Health Canada Research Licence with sensory evaluation of cannabis via human testing.
Jason McBride, Corporate Development
604-283-2301 (ext. 219)
On behalf of the Board of Directors of the Company,
Kevin Keagan, CFO
Certain statements contained in this press release constitute "forward-looking statements" within the meaning of applicable securities laws. All statements other than statements of historical fact contained in this press release, including, without limitation, statements regarding the Company's anticipated delivery of its products to provincial markets across Canada and those regarding the Company's strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company's MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The Canadian Securities Exchange has not reviewed or approved the contents of this press release.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Sign up for free stock news alerts at Investorideas.com